Saturday
April
18
2015
8:12 am
Weather

  Home
  Local News
  State / National / World
  Sports
  Opinion / Letters
  Business
  Arts / Entertainment
  Lifestyle
  Obituaries
  Calendar
  Submit Event
  Comics / Games
  Classifieds
  DJ Designers
  Archives
  Advertise With Us
  About Us
 
 
 
 
Proxy fight looms in Allergan-Valeant dispute
June 03, 2014, 05:00 AM The Associated Press

NEW YORK — Activist investor Bill Ackman says he will move to replace most of the board of directors of Allergan as part of a continuing battle for control of the company.

Ackman’s Pershing Square Capital Management and Canadian drugmaker Valeant Pharmaceuticals International Inc. want to buy Allergan, but the company has rejected their offers. Ackman says he wants to call a special shareholder meeting and will move to replace most of Allergan’s board members.

Ackman says the meeting could happen between early August and late November.

Botox-maker Allergan Inc. is urging shareholders to hold off taking action on Ackman’s proposal while the company’s board weighs the latest buyout proposal. Valeant and Pershing Square on Friday sweetened their offer to $53 billion in cash and Valeant stock.

 

 

Tags: allergan, valeant, board, ackman,


Other stories from today:

 

 
Print this Page Print this Page  |  Bookmark and Share
<< Back
 
Return To Archives
 
  


 
 
 
Daily Journal Quick Poll
 
What do you think of proposed standards by the USDA for organic seafood?

It's good, I look forward to them
Wouldn't buy it because it's farmed
Think it's silly
Will likely mean prices will rise
Hard to enforce

 

 
 
 
 
 
 
 
 
  
 
  
 
©2015 San Mateo Daily Journal
San Mateo County high school sports